(±)-pyrapyridolol, a new pyrazolo[1,5-a]pyridine derivative, inhibits 5-HT1A receptor-mediated behavior in mice

Pharmacology Reviews and Communications

Volumn 12, Issue 4, 2002, Pages 197-203

  Yamada, Jun ^a   Sugimoto, Yumi ^a   Miki, Yasuyoshi ^b   Hotta, Yoshihiro ^c   Miyazeki, Kunihiro ^c  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 HT syndrome; 5 HT1A receptor; Pindolol; Pyrapyridol

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; PINDOLOL; PYRAPYRIDOLOL; PYRAZOLOPYRIMIDINE DERIVATIVE; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; TRYPTAMINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENANTIOMER; HEAD MOVEMENT; HEAD TWITCH; HINDLIMB; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN SYNDROME;

EID: 0036819396     PISSN: 10288945     EISSN: None     Source Type: Journal    
DOI: 10.1080/10604450214702     Document Type: Article

References (20)

1. Artigas F. (1995) Pindolol, 5-hydroxytryptamine and antidepressant augmentation. Archives of General Psychiatry, 52, 969-971.
2. 1A receptor antagonist. Polish Journal of Pharmacology, 51, 405-413.
3. Edwars E. and Whiaker-Azmita P.M. (1987) Selective beta-antagonists are equally and highly potent at 5-HT sites in the rat hippocampus. Neuropharmacology, 26, 93-98.
4. Fuller R.W. (1992) Effects of p-chloroamphetamine on brain serotonin neurons. Neurochemical Research, 17, 449-456.
5. Graeff F.G., Guimaraes F.S., De Andrade T.G. and Deakin J.F. (1996) Role of 5-HT in stress, anxiety and depression. Pharmacology Biochemistry and Behavior, 54, 129-141.
6. Green A.R. and Backus L.I. (1990) Animal models of serotonin behavior. Annals of the New York Academy of Science, 600, 237-249.
7. Hoyer D. and Martin G. (1997) 5-HT receptor classification and nomenclature: Towards a harmonization with the human genome. Neuropharmacology, 36, 419-428.
8. 1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. British Journal of Pharmacology, 103, 2016-2020.
9. 1A receptor antagonist. Pharmacology, Biochemistry and Behavior, 38, 555-559.
10. Miki Y., Tasaka J., Uemura K., Miyazeki K. and Yamada J. (1996) Synthesis of 1-isopropylamino-3-)pyrazolo[1,5-a]- pyridyloxy)-2-propanols. Heterocycles, 43, 2249-2256.
11. 1A receptor activation. British Journal of Pharmacology, 106, 603-609.
12. 1A receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers. Biochemical Pharmacology, 37, 3429-3433.
13. 1A receptor ligands in a chronic mild stress model of depression. Neuropharmacology, 34, 1305-1310.
14. 1A agonist 8-OH-DPAT. Psychopharmacology, 133, 343-346.
15. 1A receptor antagonist, in the murine elevated plus-maze test. European Journal of Pharmacology, 261, 321-325.
16. 1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer's disease. Current Pharmaceutical Design, 8, 139-145.
17. Siever L.J., Kahn R.S., Lawlor B.A., Trestman R.L., Lawrence T.L. and Coccaro E.F. (1991) Critical issues in defining the role of serotonin in psychiatric disorders. Pharmacological Reviews, 43, 509-525.
18. 1A receptor and of the catecholaminergic systems in the behavioral response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. European Journal of Pharmacology, 106, 271-282.
19. Tricklebank M.D., Forler C., Middlemiss D.N. and Fozard J.R. (1985) Subtypes of the 5-HT receptor mediating the behavioural responses to 5-meththoxy-N,N-dimethyltryptamine in the rat. European Journal of Pharmacology, 117, 15-24.
20. 1A receptor in 5-HT syndrome induced in mice by tryptamine. Japanese Journal of Pharmacology, 51,